Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of the Risk of Pulmonary Embolism and Coagulation Profile in Patients With SARS Coronavirus (COV-2) Lung Disease

NCT04479540 is registered in ClinicalTrials.gov with Hopital Foch as lead sponsor.

NCT NCT04479540
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04479540 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of the Risk of Pulmonary Embolism and Coagulation Profile in Patients With SARS Coronavirus (COV-2) Lung Disease
Lead sponsor
Hopital Foch
Phase
Not applicable
Overall status
Completed
Start date
May 26, 2020
Completion date
March 5, 2022
Enrollment
117 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pneumonia, viral